STARD7 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	15 studies	21% ± 5%	Explore
natural killer cell	13 studies	22% ± 5%	Explore
regulatory T cell	13 studies	19% ± 2%	Explore
plasmacytoid dendritic cell	11 studies	25% ± 7%	Explore
type I pneumocyte	10 studies	30% ± 8%	Explore
conventional dendritic cell	10 studies	26% ± 14%	Explore
CD8-positive, alpha-beta T cell	10 studies	20% ± 2%	Explore
memory B cell	9 studies	18% ± 2%	Explore
naive B cell	9 studies	19% ± 3%	Explore
endothelial cell	9 studies	26% ± 8%	Explore
endothelial cell of lymphatic vessel	8 studies	20% ± 5%	Explore
basal cell	8 studies	21% ± 8%	Explore
CD16-positive, CD56-dim natural killer cell, human	8 studies	24% ± 4%	Explore
CD16-negative, CD56-bright natural killer cell, human	7 studies	23% ± 2%	Explore
mature NK T cell	7 studies	18% ± 2%	Explore
dendritic cell	7 studies	33% ± 17%	Explore
gamma-delta T cell	7 studies	25% ± 8%	Explore
T cell	6 studies	21% ± 5%	Explore
CD4-positive, alpha-beta T cell	6 studies	19% ± 2%	Explore
classical monocyte	6 studies	24% ± 8%	Explore
mucosal invariant T cell	6 studies	19% ± 3%	Explore
epithelial cell	6 studies	39% ± 17%	Explore
macrophage	6 studies	21% ± 5%	Explore
plasma cell	5 studies	31% ± 11%	Explore
plasmablast	5 studies	39% ± 19%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	21% ± 2%	Explore
hematopoietic precursor cell	5 studies	25% ± 5%	Explore
ciliated cell	5 studies	26% ± 9%	Explore
abnormal cell	5 studies	27% ± 9%	Explore
CD8-positive, alpha-beta memory T cell	5 studies	24% ± 5%	Explore
oligodendrocyte	5 studies	24% ± 6%	Explore
non-classical monocyte	4 studies	27% ± 9%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	18% ± 1%	Explore
myeloid cell	4 studies	24% ± 6%	Explore
immature B cell	4 studies	20% ± 3%	Explore
cardiac muscle cell	4 studies	21% ± 3%	Explore
goblet cell	4 studies	22% ± 6%	Explore
ionocyte	3 studies	25% ± 4%	Explore
neuron	3 studies	31% ± 10%	Explore
smooth muscle cell	3 studies	19% ± 3%	Explore
precursor B cell	3 studies	24% ± 2%	Explore
pro-B cell	3 studies	23% ± 6%	Explore
retinal cone cell	3 studies	39% ± 9%	Explore
retinal rod cell	3 studies	20% ± 3%	Explore
monocyte	3 studies	22% ± 5%	Explore
germinal center B cell	3 studies	24% ± 1%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	18% ± 2%	Explore
GABAergic neuron	3 studies	38% ± 3%	Explore
glutamatergic neuron	3 studies	50% ± 4%	Explore
oligodendrocyte precursor cell	3 studies	25% ± 6%	Explore
granulocyte monocyte progenitor cell	3 studies	21% ± 2%	Explore
enteroendocrine cell	3 studies	24% ± 10%	Explore
intestinal crypt stem cell	3 studies	24% ± 6%	Explore
erythroblast	3 studies	30% ± 11%	Explore
astrocyte	3 studies	21% ± 3%	Explore
CD4-positive, alpha-beta memory T cell	3 studies	18% ± 2%	Explore
hepatocyte	3 studies	39% ± 19%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	9 studies	20% ± 6%	Explore
brain	5 studies	35% ± 7%	Explore
lung	4 studies	20% ± 4%	Explore
bone marrow	3 studies	18% ± 2%	Explore
eye	3 studies	22% ± 3%	Explore
kidney	3 studies	16% ± 1%	Explore
intestine	3 studies	24% ± 8%	Explore
liver	3 studies	32% ± 11%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
brain	100%	8218.68	2642 / 2642	100%	212.81	705 / 705
breast	100%	5610.75	459 / 459	100%	152.70	1118 / 1118
liver	100%	4662.11	226 / 226	100%	87.00	406 / 406
esophagus	100%	5579.10	1444 / 1445	100%	113.34	183 / 183
thymus	100%	8496.32	653 / 653	100%	120.25	604 / 605
intestine	100%	6563.58	966 / 966	100%	128.79	526 / 527
prostate	100%	5800.11	245 / 245	100%	118.89	501 / 502
uterus	100%	4853.01	170 / 170	100%	127.57	458 / 459
ovary	100%	4018.21	180 / 180	100%	117.18	429 / 430
pancreas	100%	4235.77	327 / 328	100%	86.84	178 / 178
lung	100%	7785.40	576 / 578	100%	150.31	1155 / 1155
stomach	100%	5386.61	359 / 359	100%	112.21	285 / 286
bladder	100%	5227.90	21 / 21	100%	117.56	502 / 504
skin	100%	6787.79	1809 / 1809	100%	162.52	470 / 472
kidney	100%	7302.21	89 / 89	99%	103.45	895 / 901
adrenal gland	100%	9395.17	258 / 258	94%	71.21	216 / 230
adipose	100%	5540.38	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	132.73	80 / 80
lymph node	0%	0	0 / 0	100%	190.66	29 / 29
muscle	100%	17392.06	803 / 803	0%	0	0 / 0
spleen	100%	8337.28	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	153.57	45 / 45
ureter	0%	0	0 / 0	100%	44.84	1 / 1
blood vessel	100%	4036.08	1329 / 1335	0%	0	0 / 0
heart	97%	9433.98	838 / 861	0%	0	0 / 0
peripheral blood	84%	5013.00	781 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0005741	Cellular component	mitochondrial outer membrane
GO_0008289	Molecular function	lipid binding
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	STARD7
Protein name	StAR related lipid transfer domain containing 7 Alternative protein STARD7 StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)
Synonyms	GTT1
Description	FUNCTION: May play a protective role in mucosal tissues by preventing exaggerated allergic responses. .
Accessions	ENST00000337288.10 ENST00000443962.1 C9JTD3 Q9NQZ5 L8E753

STARD7 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review